Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy

Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) a...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cancer research (Chicago, Ill.) Ročník 77; číslo 18; s. 5054
Hlavní autori: Mapuskar, Kranti A, Flippo, Kyle H, Schoenfeld, Joshua D, Riley, Dennis P, Strack, Stefan, Hejleh, Taher Abu, Furqan, Muhammad, Monga, Varun, Domann, Frederick E, Buatti, John M, Goswami, Prabhat C, Spitz, Douglas R, Allen, Bryan G
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 15.09.2017
Predmet:
ISSN:1538-7445, 1538-7445
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemotherapy and IR (∼70%-80% killing) relative to young fibroblasts (5 months and 1 year; ∼10%-20% killing) and adult fibroblasts (20 years old; ∼10%-30% killing). Old fibroblasts also displayed significantly increased (2-4-fold) steady-state levels of O , O consumption, and mitochondrial membrane potential as well as significantly decreased (40%-50%) electron transport chain (ETC) complex I, II, IV, V, and aconitase (70%) activities, decreased ATP levels, and significantly altered mitochondrial structure. Following adenoviral-mediated overexpression of SOD2 activity (5-7-fold), mitochondrial ETC activity and aconitase activity were restored, demonstrating a role for mitochondrial O in these effects. Old fibroblasts also demonstrated elevated levels of endogenous DNA damage that were increased following treatment with IR and chemotherapy. Most importantly, treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing. These results support the hypothesis that age-associated increased O and resulting DNA damage mediate the increased susceptibility of old fibroblasts to IR and chemotherapy that can be mitigated by GC4419. .
AbstractList Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemotherapy and IR (∼70%-80% killing) relative to young fibroblasts (5 months and 1 year; ∼10%-20% killing) and adult fibroblasts (20 years old; ∼10%-30% killing). Old fibroblasts also displayed significantly increased (2-4-fold) steady-state levels of O , O consumption, and mitochondrial membrane potential as well as significantly decreased (40%-50%) electron transport chain (ETC) complex I, II, IV, V, and aconitase (70%) activities, decreased ATP levels, and significantly altered mitochondrial structure. Following adenoviral-mediated overexpression of SOD2 activity (5-7-fold), mitochondrial ETC activity and aconitase activity were restored, demonstrating a role for mitochondrial O in these effects. Old fibroblasts also demonstrated elevated levels of endogenous DNA damage that were increased following treatment with IR and chemotherapy. Most importantly, treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing. These results support the hypothesis that age-associated increased O and resulting DNA damage mediate the increased susceptibility of old fibroblasts to IR and chemotherapy that can be mitigated by GC4419. .
Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemotherapy and IR (∼70%-80% killing) relative to young fibroblasts (5 months and 1 year; ∼10%-20% killing) and adult fibroblasts (20 years old; ∼10%-30% killing). Old fibroblasts also displayed significantly increased (2-4-fold) steady-state levels of O2•-, O2 consumption, and mitochondrial membrane potential as well as significantly decreased (40%-50%) electron transport chain (ETC) complex I, II, IV, V, and aconitase (70%) activities, decreased ATP levels, and significantly altered mitochondrial structure. Following adenoviral-mediated overexpression of SOD2 activity (5-7-fold), mitochondrial ETC activity and aconitase activity were restored, demonstrating a role for mitochondrial O2•- in these effects. Old fibroblasts also demonstrated elevated levels of endogenous DNA damage that were increased following treatment with IR and chemotherapy. Most importantly, treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing. These results support the hypothesis that age-associated increased O2•- and resulting DNA damage mediate the increased susceptibility of old fibroblasts to IR and chemotherapy that can be mitigated by GC4419. Cancer Res; 77(18); 5054-67. ©2017 AACR.Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemotherapy and IR (∼70%-80% killing) relative to young fibroblasts (5 months and 1 year; ∼10%-20% killing) and adult fibroblasts (20 years old; ∼10%-30% killing). Old fibroblasts also displayed significantly increased (2-4-fold) steady-state levels of O2•-, O2 consumption, and mitochondrial membrane potential as well as significantly decreased (40%-50%) electron transport chain (ETC) complex I, II, IV, V, and aconitase (70%) activities, decreased ATP levels, and significantly altered mitochondrial structure. Following adenoviral-mediated overexpression of SOD2 activity (5-7-fold), mitochondrial ETC activity and aconitase activity were restored, demonstrating a role for mitochondrial O2•- in these effects. Old fibroblasts also demonstrated elevated levels of endogenous DNA damage that were increased following treatment with IR and chemotherapy. Most importantly, treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing. These results support the hypothesis that age-associated increased O2•- and resulting DNA damage mediate the increased susceptibility of old fibroblasts to IR and chemotherapy that can be mitigated by GC4419. Cancer Res; 77(18); 5054-67. ©2017 AACR.
Author Strack, Stefan
Goswami, Prabhat C
Riley, Dennis P
Furqan, Muhammad
Allen, Bryan G
Schoenfeld, Joshua D
Buatti, John M
Hejleh, Taher Abu
Mapuskar, Kranti A
Flippo, Kyle H
Domann, Frederick E
Spitz, Douglas R
Monga, Varun
Author_xml – sequence: 1
  givenname: Kranti A
  surname: Mapuskar
  fullname: Mapuskar, Kranti A
  organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa
– sequence: 2
  givenname: Kyle H
  surname: Flippo
  fullname: Flippo, Kyle H
  organization: Department of Pharmacology, The University of Iowa, Iowa City, Iowa
– sequence: 3
  givenname: Joshua D
  surname: Schoenfeld
  fullname: Schoenfeld, Joshua D
  organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa
– sequence: 4
  givenname: Dennis P
  surname: Riley
  fullname: Riley, Dennis P
  organization: Galera Therapeutics, Inc., Malvern, Pennsylvania
– sequence: 5
  givenname: Stefan
  surname: Strack
  fullname: Strack, Stefan
  organization: Department of Pharmacology, The University of Iowa, Iowa City, Iowa
– sequence: 6
  givenname: Taher Abu
  surname: Hejleh
  fullname: Hejleh, Taher Abu
  organization: Department of Internal Medicine, The University of Iowa, Iowa City, Iowa
– sequence: 7
  givenname: Muhammad
  surname: Furqan
  fullname: Furqan, Muhammad
  organization: Department of Internal Medicine, The University of Iowa, Iowa City, Iowa
– sequence: 8
  givenname: Varun
  surname: Monga
  fullname: Monga, Varun
  organization: Department of Internal Medicine, The University of Iowa, Iowa City, Iowa
– sequence: 9
  givenname: Frederick E
  surname: Domann
  fullname: Domann, Frederick E
  organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa
– sequence: 10
  givenname: John M
  surname: Buatti
  fullname: Buatti, John M
  organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa
– sequence: 11
  givenname: Prabhat C
  surname: Goswami
  fullname: Goswami, Prabhat C
  organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa
– sequence: 12
  givenname: Douglas R
  surname: Spitz
  fullname: Spitz, Douglas R
  organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa
– sequence: 13
  givenname: Bryan G
  surname: Allen
  fullname: Allen, Bryan G
  email: bryan-allen@uiowa.edu
  organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa. bryan-allen@uiowa.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28765155$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtPwzAQhC1URB_wE0A-ckmxEztOjlGhtFIBice52sRbapTEwXYkyq8nEkXisrOHb0aamZJRa1sk5JKzOecyu2GMZZEUKp4viseIq4hxlp6QCZdJFikh5OjfPyZT7z8Gi-RMnpFxnKlUcikn5PvBBFvtbaudgZq-9B06-2U00nVbOQSPnhbvGBXe28pAQD0wvsIumNLUJhyo3dFV30BLb9E1Q8TSlM6WNfjgabD0GfRgM7al0Gq62GNjwx4ddIdzcrqD2uPFUWfkbXn3ulhFm6f79aLYRJVkMkSJSCqBOgMFeT5clfBEYYKQ7UqRM1GKMhUlgNZaZcArZOlAiVgzrTCVcTwj17-5nbOfPfqwbczQoK6hRdv7Lc9jKTlnnA_o1RHtywb1tnOmAXfY_u0V_wA2WnHg
CitedBy_id crossref_primary_10_1016_j_freeradbiomed_2019_11_012
crossref_primary_10_1016_j_jksus_2021_101655
crossref_primary_10_1016_j_isci_2023_106314
crossref_primary_10_1155_2018_2468457
crossref_primary_10_1093_cercor_bhz052
crossref_primary_10_3390_ijms25168885
crossref_primary_10_1161_JAHA_124_039216
crossref_primary_10_1016_j_freeradbiomed_2025_09_013
crossref_primary_10_1126_scitranslmed_abb3768
crossref_primary_10_1007_s00249_020_01460_x
crossref_primary_10_1142_S0192415X22500586
crossref_primary_10_1667_RR15101_1
crossref_primary_10_1016_j_cmet_2020_09_012
crossref_primary_10_3390_antiox10091329
crossref_primary_10_1172_JCI120844
crossref_primary_10_1007_s00210_023_02559_6
crossref_primary_10_1080_09553002_2021_1956007
crossref_primary_10_1016_j_semradonc_2018_10_005
crossref_primary_10_2147_DDDT_S267400
crossref_primary_10_3390_antiox13050587
crossref_primary_10_1016_j_redox_2018_09_020
crossref_primary_10_1016_j_cell_2022_12_027
crossref_primary_10_3389_fmolb_2025_1638042
crossref_primary_10_1016_j_drudis_2023_103626
crossref_primary_10_1016_j_freeradbiomed_2020_07_032
crossref_primary_10_1155_2019_4278658
crossref_primary_10_3390_antiox7010018
crossref_primary_10_1089_ars_2023_0491
ContentType Journal Article
Copyright 2017 American Association for Cancer Research.
Copyright_xml – notice: 2017 American Association for Cancer Research.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1158/0008-5472.CAN-17-0106
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7445
ExternalDocumentID 28765155
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIEHS NIH HHS
  grantid: P30 ES005605
– fundername: NCI NIH HHS
  grantid: T32 CA078586
– fundername: NIGMS NIH HHS
  grantid: T32 GM007337
– fundername: NCI NIH HHS
  grantid: R01 CA182804
– fundername: NCI NIH HHS
  grantid: R01 CA111365
– fundername: NCI NIH HHS
  grantid: P30 CA086862
– fundername: NINDS NIH HHS
  grantid: R01 NS056244
GroupedDBID ---
-ET
18M
29B
2WC
34G
39C
53G
5GY
5RE
5VS
6J9
AAJMC
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AETEA
AFHIN
AFOSN
AFRAH
AFUMD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
EBS
ECM
EIF
EJD
F5P
FRP
GX1
H13
IH2
KQ8
L7B
LSO
NPM
OK1
P0W
P2P
PQQKQ
RCR
RHI
RNS
SJN
TR2
W2D
W8F
WH7
WOQ
YKV
YZZ
7X8
AAFWJ
ABUFD
ID FETCH-LOGICAL-c505t-343c4ed8a7a998a773137e3ea8fb4904b4b64baaddd78a1ce068a742d0d7e6522
IEDL.DBID 7X8
ISICitedReferencesCount 33
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000410945700027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1538-7445
IngestDate Sun Nov 09 10:10:08 EST 2025
Thu Apr 03 07:11:27 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Language English
License 2017 American Association for Cancer Research.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-343c4ed8a7a998a773137e3ea8fb4904b4b64baaddd78a1ce068a742d0d7e6522
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://cancerres.aacrjournals.org/content/canres/77/18/5054.full.pdf
PMID 28765155
PQID 1925511011
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1925511011
pubmed_primary_28765155
PublicationCentury 2000
PublicationDate 2017-09-15
PublicationDateYYYYMMDD 2017-09-15
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer research (Chicago, Ill.)
PublicationTitleAlternate Cancer Res
PublicationYear 2017
References 19426871 - Methods Enzymol. 2009;457:231-53
13738472 - J Biol Chem. 1960 Nov;235:3322-9
15134509 - Curr Med Chem. 2004 May;11(9):1105-12
16885361 - Cancer Res. 2006 Aug 1;66(15):7615-20
4354035 - Arch Biochem Biophys. 1973 Sep;158(1):396-400
19803744 - Antioxid Redox Signal. 2010 Jun 15;12(12):1431-70
17242670 - Cancer Control. 2007 Jan;14(1):44-56
5016631 - J Am Geriatr Soc. 1972 Apr;20(4):145-7
17406473 - Nat Protoc. 2006;1(5):2315-9
25706776 - Radiat Res. 2015 Mar;183(3):262-70
197811 - Adv Exp Med Biol. 1977;78:67-82
26184181 - Int J Mol Sci. 2015 Jul 13;16(7):15918-53
21050134 - Antioxid Redox Signal. 2011 Sep 15;15(6):1669-78
27794421 - J Invest Dermatol. 2017 Mar;137(3):576-586
19812404 - N Engl J Med. 2009 Oct 8;361(15):1475-85
25058905 - Eur J Pharmacol. 2014 Oct 5;740:364-78
23849169 - Radiother Oncol. 2013 Sep;108(3):362-9
8192914 - Biochem Med Metab Biol. 1994 Feb;51(1):35-42
21285760 - Plast Reconstr Surg. 2011 Feb;127(2):560-8
14907713 - J Biol Chem. 1951 Nov;193(1):265-75
7501808 - Radiother Oncol. 1995 Aug;36(2):107-20
23190879 - J Invest Dermatol. 2013 Apr;133(4):1088-96
12600822 - Am J Respir Cell Mol Biol. 2003 Jul;29(1):88-97
19929420 - Radiat Res. 2009 Dec;172(6):737-45
26636574 - PLoS One. 2015 Dec 04;10(12):e0143007
18610740 - In Vivo. 2008 May-Jun;22(3):305-9
2547324 - Anal Biochem. 1989 May 15;179(1):8-18
22334657 - J Biol Chem. 2012 Mar 30;287(14):10990-1001
22689576 - J Biol Chem. 2012 Aug 3;287(32):27255-64
8761419 - Carcinogenesis. 1996 Aug;17(8):1633-9
13096460 - J Appl Physiol. 1953 Sep;6(3):189-93
21659507 - J Biol Chem. 2011 Aug 5;286(31):27103-10
26589414 - Pharmacol Rev. 2016 Jan;68(1):20-48
11966833 - Eur J Cancer Care (Engl). 2002 Mar;11(1):33-43
9458810 - Am J Physiol. 1998 Jan;274(1 Pt 1):L127-33
16911562 - Aging Cell. 2006 Oct;5(5):379-89
17436562 - In Vivo. 2007 Mar-Apr;21(2):141-6
15197331 - Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):311-22
20195383 - Aging (Albany NY). 2009 May 22;1(6):557-72
23317514 - Curr Opin Genet Dev. 2013 Feb;23(1):53-62
14580310 - Antioxid Redox Signal. 2003 Oct;5(5):557-61
12054921 - Methods. 2002 Apr;26(4):307-16
22016654 - Int J Mol Sci. 2011;12(9):6226-39
11517304 - Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10469-74
19403886 - J Clin Oncol. 2009 Jun 10;27(17):2758-65
18508680 - Front Biosci. 2008 May 01;13:6554-79
27247702 - Oxid Med Cell Longev. 2016;2016:3565127
15647387 - Am J Physiol Cell Physiol. 2005 Jun;288(6):C1440-50
References_xml – reference: 22689576 - J Biol Chem. 2012 Aug 3;287(32):27255-64
– reference: 19929420 - Radiat Res. 2009 Dec;172(6):737-45
– reference: 13096460 - J Appl Physiol. 1953 Sep;6(3):189-93
– reference: 19812404 - N Engl J Med. 2009 Oct 8;361(15):1475-85
– reference: 27247702 - Oxid Med Cell Longev. 2016;2016:3565127
– reference: 23849169 - Radiother Oncol. 2013 Sep;108(3):362-9
– reference: 22016654 - Int J Mol Sci. 2011;12(9):6226-39
– reference: 2547324 - Anal Biochem. 1989 May 15;179(1):8-18
– reference: 22334657 - J Biol Chem. 2012 Mar 30;287(14):10990-1001
– reference: 13738472 - J Biol Chem. 1960 Nov;235:3322-9
– reference: 14580310 - Antioxid Redox Signal. 2003 Oct;5(5):557-61
– reference: 4354035 - Arch Biochem Biophys. 1973 Sep;158(1):396-400
– reference: 26184181 - Int J Mol Sci. 2015 Jul 13;16(7):15918-53
– reference: 19426871 - Methods Enzymol. 2009;457:231-53
– reference: 16885361 - Cancer Res. 2006 Aug 1;66(15):7615-20
– reference: 17406473 - Nat Protoc. 2006;1(5):2315-9
– reference: 15647387 - Am J Physiol Cell Physiol. 2005 Jun;288(6):C1440-50
– reference: 20195383 - Aging (Albany NY). 2009 May 22;1(6):557-72
– reference: 18610740 - In Vivo. 2008 May-Jun;22(3):305-9
– reference: 17436562 - In Vivo. 2007 Mar-Apr;21(2):141-6
– reference: 23317514 - Curr Opin Genet Dev. 2013 Feb;23(1):53-62
– reference: 19803744 - Antioxid Redox Signal. 2010 Jun 15;12(12):1431-70
– reference: 12054921 - Methods. 2002 Apr;26(4):307-16
– reference: 23190879 - J Invest Dermatol. 2013 Apr;133(4):1088-96
– reference: 7501808 - Radiother Oncol. 1995 Aug;36(2):107-20
– reference: 15197331 - Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):311-22
– reference: 21285760 - Plast Reconstr Surg. 2011 Feb;127(2):560-8
– reference: 14907713 - J Biol Chem. 1951 Nov;193(1):265-75
– reference: 197811 - Adv Exp Med Biol. 1977;78:67-82
– reference: 9458810 - Am J Physiol. 1998 Jan;274(1 Pt 1):L127-33
– reference: 5016631 - J Am Geriatr Soc. 1972 Apr;20(4):145-7
– reference: 11966833 - Eur J Cancer Care (Engl). 2002 Mar;11(1):33-43
– reference: 16911562 - Aging Cell. 2006 Oct;5(5):379-89
– reference: 8192914 - Biochem Med Metab Biol. 1994 Feb;51(1):35-42
– reference: 19403886 - J Clin Oncol. 2009 Jun 10;27(17):2758-65
– reference: 21659507 - J Biol Chem. 2011 Aug 5;286(31):27103-10
– reference: 17242670 - Cancer Control. 2007 Jan;14(1):44-56
– reference: 27794421 - J Invest Dermatol. 2017 Mar;137(3):576-586
– reference: 18508680 - Front Biosci. 2008 May 01;13:6554-79
– reference: 26636574 - PLoS One. 2015 Dec 04;10(12):e0143007
– reference: 15134509 - Curr Med Chem. 2004 May;11(9):1105-12
– reference: 12600822 - Am J Respir Cell Mol Biol. 2003 Jul;29(1):88-97
– reference: 8761419 - Carcinogenesis. 1996 Aug;17(8):1633-9
– reference: 25706776 - Radiat Res. 2015 Mar;183(3):262-70
– reference: 25058905 - Eur J Pharmacol. 2014 Oct 5;740:364-78
– reference: 11517304 - Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10469-74
– reference: 21050134 - Antioxid Redox Signal. 2011 Sep 15;15(6):1669-78
– reference: 26589414 - Pharmacol Rev. 2016 Jan;68(1):20-48
SSID ssj0005105
Score 2.4084754
Snippet Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 5054
SubjectTerms Adult
Age Factors
Aged
Animals
Antineoplastic Agents - adverse effects
Apoptosis - drug effects
Apoptosis - radiation effects
Cell Proliferation - drug effects
Cell Proliferation - radiation effects
Cells, Cultured
Cisplatin - adverse effects
Fibroblasts - drug effects
Fibroblasts - pathology
Fibroblasts - radiation effects
Humans
Male
Membrane Potential, Mitochondrial - drug effects
Membrane Potential, Mitochondrial - radiation effects
Mice
Mice, Inbred C57BL
Mitochondria - drug effects
Mitochondria - pathology
Mitochondria - radiation effects
Oxidative Stress
Radiation, Ionizing
Skin - drug effects
Skin - pathology
Skin - radiation effects
Superoxide Dismutase - metabolism
Superoxides - metabolism
Young Adult
Title Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy
URI https://www.ncbi.nlm.nih.gov/pubmed/28765155
https://www.proquest.com/docview/1925511011
Volume 77
WOSCitedRecordID wos000410945700027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvAa7Sab7PYkpVq8NBQf0FvYZCdSkKSaVKy_3pkkpSdB8JLTBpbdb2a-2XkxdqWFiQMXPVWDxhIdFC1Q5rTnUGs4X4OKpZtWwyZUGOrxuDtqHtyKJq1yoRMrRW3zhN7Ib5CJoHFHAInb6btDU6MoutqM0FhlLQ-pDKFajZfdwv06hbESaiWl31TwCF9TAYN2fKnc634vdASlX3aC31lmZW0G2__d5w7bangm79XA2GUrkO2xjWETSd9n30MUZVR9mSUE8qcZNQz_mljgqDEoUR0K3nsFZ3F9YHFNUeXAVOm0c56nvIoA8DtS7m98gI53HiMZLwte5vyRmh7QrXOTWU59CZpar_kBexncP_cfnGYOg5MgPyodT3qJBKuNMuicGaXwrBV4YHQay25HxjIOZGxQU1qljUigE-Aq6dqOVRAgwTtka1mewTHjCpRGyuMbDYiCGBEkyGMBoVPkJbbbZpeLU40Q5xS8MBnksyJanmubHdVXE03rhhwRen000d0_-cPfp2zTJctMUyD8M9ZKUcrhnK0nn-Wk-LioAITfcDT8AbZ1z4s
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mitochondrial+Superoxide+Increases+Age-Associated+Susceptibility+of+Human+Dermal+Fibroblasts+to+Radiation+and+Chemotherapy&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Mapuskar%2C+Kranti+A&rft.au=Flippo%2C+Kyle+H&rft.au=Schoenfeld%2C+Joshua+D&rft.au=Riley%2C+Dennis+P&rft.date=2017-09-15&rft.issn=1538-7445&rft.eissn=1538-7445&rft.volume=77&rft.issue=18&rft.spage=5054&rft_id=info:doi/10.1158%2F0008-5472.CAN-17-0106&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7445&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7445&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7445&client=summon